Iperionx Ltd.

As of December 31, 2024, Iperionx Ltd. carries a market capitalization of 1.74B, placing it among publicly traded companies globally. Its enterprise value stands at 1.62B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Iperionx Ltd.'s next confirmed earnings release is scheduled for March 16, 2027.

As of December 31, 2024, Iperionx Ltd. has 315.85M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Iperionx Ltd. maintains a current ratio of 11.80, meaning it holds 11.8x the short-term assets needed to cover near-term liabilities.

As of the close on October 22, 2026, Iperionx Ltd.'s stock has declined approximately 75.78% over the past 52 weeks. The 50-day moving average sits at 2.68, while the 200-day moving average is 4.39.

As of December 31, 2024, Iperionx Ltd. holds 124.59M in cash and equivalents against 6.77M in total debt, resulting in a net debt position of -124.55M. Total book value stands at 170.49M, with working capital of 116.48M providing operational flexibility.

These figures cover the twelve months ended December 31, 2024.

Over the twelve months ended December 31, 2024, Iperionx Ltd. paid dividends of - - per share. Total shareholder yield is negative at -8.97, meaning Iperionx Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.